Cristina Royo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.

Journal: Blood
Published: March 15, 2018

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Journal: Leukemia
Published: April 19, 2017

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.

Journal: European journal of haematology
Published: November 03, 2015

Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis.

Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis.

Journal: Blood cancer journal
Published: October 03, 2015

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Journal: Blood
Published: July 18, 2015

Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.

Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 20, 2015

Non-coding recurrent mutations in chronic lymphocytic leukaemia.

Non-coding recurrent mutations in chronic lymphocytic leukaemia.

Journal: Nature
Published: February 23, 2015

Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia.

Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia.

Journal: Blood
Published: October 06, 2014

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.

Journal: Haematologica
Published: July 06, 2014

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model.

Journal: Haematologica
Published: June 29, 2014

Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.

Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.

Journal: The Journal of pathology
Published: May 23, 2014

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.

Journal: Haematologica
Published: April 05, 2014
Showing 1-12 of 22

Last Updated: 09/26/2026